Retatrutide has emerged as a new medication in the fight against obesity. This groundbreaking drug, categorized as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in clinical trials. By https://aishapkdh715524.tblogz.com/retatrutide-a-promising-new-treatment-for-obesity-49527315